Device Devices

Unicel Dxi Access

Payments companies reported to CMS as associated with Unicel Dxi Access. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$2,287associated payments (2023-2025)
39clinicians with associated payments
1company reporting

By year

2023 $1,167
2024 $839
2025 $282

Payments reported as associated with Unicel Dxi Access, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Anatomic Pathology & Clinical Pathology $1,316
Emergency Medicine $344
Family Medicine $311
Nurse Practitioner $48.40
Thoracic Surgery (Cardiothoracic Vascular Surgery) $46.80
Clinical Pathology/Laboratory Medicine $36.76

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Unicel Dxi Access

These are the largest totals companies reported as associated with Unicel Dxi Access. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Michelle Zimmerman Indianapolis, IN Anatomic Pathology & Clinical Pathology $932.54
Jeffery Dunkelberger Enola, PA Family Medicine $286.90
David Huddleston Fayetteville, NC Anatomic Pathology & Clinical Pathology $87.97
Ajay Patel Winfield, IL Anatomic Pathology & Clinical Pathology $61.82
Achintya Moulick Philadelphia, PA Thoracic Surgery (Cardiothoracic Vascular Surgery) $46.80
Timothy Skelton Burlington, MA Clinical Pathology/Laboratory Medicine $36.76
David Nash Salem, OH Anatomic Pathology & Clinical Pathology $33.17
Joseph Miller Detroit, MI Emergency Medicine $29.42
Brien Smith Detroit, MI Neurology (Psychiatry & Neurology) $29.42
Dhananjay Chitale Detroit, MI Anatomic Pathology & Clinical Pathology $29.42

Prescribed Unicel Dxi Access?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.